Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Neoplasms × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 33 Nausea 22 Neoplasms 11 Breast Neoplasms 6 Lymphoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Multiple Myeloma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Weight Loss 1 Solid Tumors 1 Sarcoma 1 Radiation Injuries 1 Pancreatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Nausea With Vomiting Chemotherapy-Induced 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1

Interventions

Oxaliplatin 25 Fluorouracil 22 Leucovorin 19 Surveys and Questionnaires 16 Irinotecan 15 Capecitabine 15 Bevacizumab 12 Cisplatin 11 Drug Therapy 10 Gemcitabine 9 Standard of Care 8 Nivolumab 8 Blood Specimen Collection 8 S 1 (combination) 6 Endoscopic Mucosal Resection 6 Cetuximab 6 pembrolizumab 5 atezolizumab 5 Sunitinib 5 Educational Status 5 Cyclophosphamide 5 Radiotherapy 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Folfox protocol 4 Everolimus 4 Docetaxel 4 130-nm albumin-bound paclitaxel 4 tegafur-gimeracil-oteracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03674294 2023-02-08

CINV

Sun Yat-sen University

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡